Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

Novartis researchers are using data to accelerate drug development.

Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.

Novartis is developing an experimental drug for weight loss.

Deep in a forest in the West African country of Ghana, two men are searching for plants that they hope could ultimately provide a cure for some of the world’s deadliest diseases.

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.

Meet Melanoma survivor TJ Sharpe in the first installment of his new blog series on Novartis.com.